Overview
Schisandrin is a dibenzocyclooctadiene lignan extracted from Schisandra chinensis berries, a plant used in Traditional Chinese Medicine for centuries. As one of the primary active components, it accounts for approximately 2-4% of dried berry weight. Modern research has validated its pharmacological effects, particularly in liver protection and stress adaptation. The compound gained WHO recognition in 2007 as a hepatoprotective agent. Industrial extraction typically involves supercritical CO2 or ethanol methods, yielding 90-95% purity for pharmaceutical applications. Its unique molecular structure enables both lipophilic and hydrophilic interactions in biological systems.
Physical and Chemical Properties
Schisandrin crystallizes in orthorhombic systems with characteristic UV absorption at 217 nm and 254 nm. The molecule contains seven chiral centers, making stereochemical purity critical for bioactivity. It demonstrates thermal stability up to 150ยฐC but degrades under prolonged UV exposure. In solution, it exhibits pH-dependent stability, remaining intact between pH 3-7. The logP value of 3.2 indicates good membrane permeability. Spectroscopic fingerprints include distinctive IR peaks at 1605 cmโ1 (aromatic C=C) and 3420 cmโ1 (phenolic OH). These properties guide quality control in industrial production.
Main Applications
In the pharmaceutical industry, schisandrin is formulated into hepatoprotective drugs for chemical-induced liver damage, with typical dosages of 50-200 mg/day. Over 30% of Chinese liver protection medications contain it as an active ingredient. Nutraceutical applications include anti-aging supplements where it combats oxidative stress through Nrf2 pathway activation. The cosmetic industry utilizes its antioxidant capacity (ORAC value โ 12,000 ฮผmol TE/g) in anti-aging serums. Emerging research explores its potential in neurodegenerative disease management, with patented formulations targeting Alzheimer's pathology. Current GMP production yields about 20 metric tons annually, primarily serving Asian markets.
Safety and Storage
Schisandrin has an LD50 > 2000 mg/kg in rodent studies, classifying it as Category 5 under GHS. Occupational exposure limits are set at 10 mg/m3 for inhalable dust. Proper handling requires NIOSH-approved N95 masks when processing powder forms. Long-term storage requires nitrogen-flushed aluminum foil bags with desiccants. Degradation products include schisandrin B and gomisin A, detectable by HPLC-UV at 254 nm. Facilities should implement IPC testing every six months for stored batches, monitoring for discoloration (ฮE < 2 on CIELAB scale) and moisture content (<3%).
B2B Procurement Guide
Bulk buyers should prioritize suppliers with ISO 13485 certification for pharmaceutical-grade material. Key procurement documents include Certificate of Analysis with: 1) HPLC purity (โฅ98%), 2) residual solvent reports (ethanol <5000 ppm), 3) heavy metal screening (Pb <3 ppm), and 4) microbial limits (TAMC <1000 CFU/g). Spot market prices fluctuate with Schisandra berry harvest yields (June-August). Contract manufacturing typically requires 60-day lead times for 100+ kg orders. Third-party testing via USP <561> methods is recommended for import/export compliance. Container options include 25 kg fiber drums (for powder) or 200L stainless steel containers (for ethanol solutions).
Related Manufacturers
- ไธป่ฅ๏ผไธญ่ฏๆ ๅๅใๆ ๅๅๅฏน็ งๅใๅคฉ็ถๅๅ็ฉใๆ ๅๅใๅๆ่ฏๅใ็ป่ๅฎ้ชใๅจ็ฉๅฎ้ชใไธญ่ฏๆๅ็ฉใๅไฝๅๅ็ฉใ็ง็ ๅฎ้ช็จ
- ไธป่ฅ๏ผๆจ่็ด ใ้ป้ ฎใๆฅๅฐ้ ฎใ่ฝ้
- ไธป่ฅ๏ผๅฏน็ งๅใๆ ๅๅใๅฝๅฝ้ ธ้ ใๆฐดๅๆฐงๅๅ่ก็ด ใไฝๆๆๅ ้ ฏใๆฐๅฝๅฝๅ ้ ฏใ่กฅ้ชจ่็ฒ็ด ใ่กฅ้ชจ่ไน็ด ใ็พๅบ่่ฏ่ทใ้ฟ้ญ้ ธๆพๆ้ ฏใ่ฑ็พ้่ก่็ณ่ท
- ไธป่ฅ๏ผๅฏน็ งๅใไธญ่ฏๅค็ณใๆฃ้ชๆฃๆตๆๅกใไธญ่ฏ็ ็ฉถๆๅกใCMO/CDMO
- ไธป่ฅ๏ผ้ฃๅ็บง็ๆฒนใๅๅ ญ้ใๅๅ ซ้ใๅๅ ญๅๅ ซ้ใๆๆก้ ธใๆฃๆฆ้ ธใ่่ฑ่ป้ ธใ็กฌ่้ ธใไธไบ้ใไบไธไบ้ใไธไธไบ้
- ไธป่ฅ๏ผ้่ๆๅ็ฉใไบๆฐขๆจๆข ็ด ใไธๆฐด่้ ธใ็กซ่พ้ ธใๅง้ป็ด ใๅถ้ป็ด ใๆฒ้ ธใๅคง้ป็ด ใ็ฝ่่ฆ้ใไผ ๆ้ ธใ่่ดจไฝNMNใๆจ็่็ด ใ่ๆ น็ด ใ็งฏ้ช่็ใL-่ฐท่ฑ็่ฝใๆฐดๆบถ้่ๆๅ็ฉ
- ไธป่ฅ๏ผๆก่็ด ใๅๅญฆ่ฏๅใฮฒ-้ฆๆ ่้ ฎ
- ไธป่ฅ๏ผๅคน็ซนๆกใๅผๅฅฅๅกใ้ฆ้้ ฎใๅฟ่ถ็ด ใ็ฝ้ฒ็ขฑใ็ฎก่ฑ่ทใ็ดซๆช่ชใๆจๆ ้ใ่ฑ็พ้ใๆค้ ธ้ใ่ๆจ็ด ใๆณฝๆณป้ใ้พ่ก็ด ใ้ปๆ้ ฎใ่ฑ่ข้ ฎใ้ฒๅทฑ็ขฑใ่ซ่ฆ็ด ใไน็ฒ็ด ใๅฐๆฅ็ด ใๅๆด้ ใ็่ทๅ ใๆ ๅๅใๅ้ป้ ฎใๆจฑๆก่ทใ่้บป็ด
- ไธป่ฅ๏ผiggๆไฝใ็ณ่็ฝใ่ฏๅ็ใๅ ่็ด ใ่่็ฝใไบบ็ฆ็ด ใ็ฒ็บค็ปดใ็ช็พ้ ฎใ็ฏไบ้ ฎใnadๆฟ้ ถใๆต่ฏ็ใ็็ฆ็ด ใ็่้ ธใๅๆ่ถใ็ฃท้ ธ้ ถใ็ฌ่พ็ด ใๅซๆฐด้ใไบบ่็ฝใ็่็ขฑใigmๆไฝใdnaๆไฝใ็ฃท่้ ถใๅคง้ผ ่ถ ใ็ฌๅถ้ ธใไบบ่้ ธใๆ ทๅไฝ
- ไธป่ฅ๏ผๅๅ ซ้ใๅๅ ญ้ ธใ่่ช้ ธใๆๆก้ ธใไธไธ้ใๅๅ ซ้ ธใๆฃๆฆ้ ธใ็กฌ่้ ธใๅไบ้ ธใ็ๅฐ่ถใ่่ช็ฒใ็ๆฒนใ่่ฑ่ป้ ธใๅไบ้ใๅๅ ญ้ใๅๅ ญๅๅ ซ้ใ็ก ๆฒนใไธไบ้ใ้ฒธ่ก็กฌ่้
- ไธป่ฅ๏ผๆๆ่็ด ใๅฏน็ งๅใๆ ๅๅ
- ไธป่ฅ๏ผ็ง็ ่ฏๅ็ใ้ ถๅ ่ฏๅ็ใelisa่ฏๅ็ใๅฐ้ผ ๅ ่็ด ใ็ๅ่ฏๅ็ใ็ป่ใ็็ฉ่ฏๅใ่ฟๅฃELISA่ฏๅ็ใPCR่ฏๅ็ใ็ๅๆต่ฏ็
- ไธป่ฅ๏ผ็ง็ ่ฏๅ็ใ้ ถๅ ่ฏๅ็ใelisa่ฏๅ็ใๅฐ้ผ ๅ ่็ด ใ็ป่ใ็็ฉ่ฏๅใ่ฟๅฃELISA่ฏๅ็ใPCR่ฏๅ็ใ็ๅๆต่ฏ็
- ไธป่ฅ๏ผELISA่ฏๅ็ใPCR่ฏๅ็ใ็ๅ่ฏๅ็ใไบบๅ ่็ด ใ็ง็ ่ฏๅ
- ไธป่ฅ๏ผ้ป่ฉ็ด ใๅคง่็ด ใๅ้้่ๆๅ็ฉใๅๆฅ่ๆๅ็ฉใ้ฏๅถๆฃ่่ช้ ธใ่ฆ่็ใ็บข่ฝฆ่ฝดๅผ้ป้ ฎใๆฐดๆบถ็ฝ่่ฆ้ใๅผๆฏๅฏๆใๆญฆ้ด่ค้ ธใไนณ้ฆ้ ธใๆด่้ ธใๅบๆขจSODใๅฒฉ่ป้ป่ดจใๆพๆ่่ท
- ไธป่ฅ๏ผELISA่ฏๅ็ใPCR่ฏๅ็ใ็ๅ่ฏๅ็ใๅ ่็ด ใ่็ฝใๆไฝใ็ป่
- ไธป่ฅ๏ผๆๆบๅๆใไธญ้ดไฝใ้ฆ็ฒพ้ฆๆใ่้บป่็ด ใๅฌๅๅใๆๆบ็ก ใ่กจ้ขๆดปๆงๅ